Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
-
Smaller, privately owned companies are becoming a key part of the local IPO market -
Government interventions staved off pandemic-related defaults, though macro headwinds are causing uncertainty
-
Verona Pharma and Borr Drilling raise capital at opportune moment
-
Finances drug company's buyout by Carlyle and PAI Partners
-
UK blocks have been few and far between in recent months
